CDNA (CDNA)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$1.90B
EV / Sales4.15
EV / EBITDA14.66
EV / Operating Cash Flow20.30
EV / Free Cash Flow22.35

Return Metrics (TTM)

Return on Equity (ROE)32.81%
Return on Assets (ROA)20.83%
Return on Invested Capital (ROIC)25.30%
Return on Capital Employed (ROCE)25.30%

Yield Metrics

Earnings Yield4.93%
Free Cash Flow Yield3.76%

Balance Sheet Strength

Net Debt / EBITDA-2.78
Current Ratio4.58
Working Capital$335.52M
Tangible Asset Value$371.07M
Net Current Asset Value$321.83M

Working Capital Efficiency

Days Sales Outstanding27.39
Days Payables Outstanding34.27
Operating Cycle (Days)52.59
Cash Conversion Cycle18.33

Capital Allocation

CapEx / Revenue1.88%
CapEx / Operating Cash Flow9.20%
R&D / Revenue17.43%
SG&A / Revenue54.07%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin66.99%
Operating Margin-5.53%
Net Profit Margin-5.62%

Solvency

Debt / Equity0.09
Quick Ratio2.56
Cash Ratio0.73

Per Share

Revenue / Share$7.13
FCF / Share$0.68
PE Ratio-47.10